Remove Coronary Artery Disease Remove Electrophysiology Remove Heart attacks
article thumbnail

Johnson and Johnson to Acquire Shockwave Medical

DAIC

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

article thumbnail

Feature | Bridging the Gender Gap in Heart Health: Women’s Specialized Clinics

American College of Cardiology

Healy, MD, FACC, published an editorial in the New England Journal of Medicine highlighting the findings of two studies in that issue demonstrating clear evidence of sex bias in the management of coronary artery disease.2 These have ranged from heart attacks, cardio-obstetrics, breast cancer, prevention and arrhythmias.8-13